Home › Funds › First Turn Management, LLC › NAMS

First Turn Management, LLC position in NAMS

NEWAMSTERDAM PHARMA COMPANY · Health Care

First Turn Management, LLC reported holding 582,497 shares of NAMS (NEWAMSTERDAM PHARMA COMPANY) in its Q2 2026 13F filing — a position valued at US$19.7M, representing 2.11% of its reported portfolio and ranking #23 among its reported holdings. First Turn Management, LLC has disclosed NAMS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)582.50K sh
Reported value held$19.74M
Portfolio Weight2.11%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's NAMS position evolved

First Turn Management, LLC first disclosed a stake in NAMS in Q2 2025 at 521,097 shares (US$9.4M). The position peaked in Q4 2025 at 893,473 shares, worth US$31.3M. Across 5 filings, First Turn Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 582,497 shares valued at US$19.7M — an increase of 24,161 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2025 (shares rose 23% over the following quarter), a 38% trim in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 521.10K $9.44M New
Q3 2025 716.97K $20.39M Add
Q4 2025 893.47K $31.34M Add
Q1 2026 558.34K $17.87M Reduce
Q2 2026 582.50K $19.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAMS and 13F data

NAMS (NEWAMSTERDAM PHARMA COMPANY) is a Health Care company. 43 other funds we track also report a position in NAMS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$613.0M), RA CAPITAL MANAGEMENT, L.P. (US$323.7M), FCPM III SERVICES B.V. (US$287.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAMS

All NAMS fund holders →

FAQ

How long has First Turn Management, LLC held NAMS?

First Turn Management, LLC has disclosed NAMS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is First Turn Management, LLC's current position in NAMS?

As of Q2 2026, First Turn Management, LLC holds 582.50K shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), valued at $19.74M, representing 2.11% of its reported portfolio and ranking #23.

Has First Turn Management, LLC been buying or selling NAMS?

In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in NAMS. The position peaked in Q4 2025 at 893.47K shares.

Which other funds hold NAMS?

Other major institutional holders of NAMS include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.